ReviewCurrent diabetes reports2026
SGLT-2 Inhibitors and GLP-1 Receptor Agonists as Combination Therapy in Type 2 Diabetes.
Aris Liakos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewCurrent diabetes reports2026
Aris Liakos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.